Effect of Raloxifene Treatment on Osteocyte Apoptosis in Postmenopausal Women

Increased osteocyte apoptosis, as the result of estrogen deficiency, could play a role in the decrease of bone mass and bone strength seen in postmenopausal osteoporosis. We investigated whether treatment with raloxifene of postmenopausal women with osteoporosis affects osteocyte apoptosis. Transili...

Descripción completa

Detalles Bibliográficos
Autores principales: van Essen, Huib W., Holzmann, Paulien J., Blankenstein, Marinus A., Lips, Paul, Bravenboer, Nathalie
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2007
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2039811/
https://www.ncbi.nlm.nih.gov/pubmed/17676256
http://dx.doi.org/10.1007/s00223-007-9050-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2039811/
https://www.ncbi.nlm.nih.gov/pubmed/17676256
http://dx.doi.org/10.1007/s00223-007-9050-0

Ejemplares similares